|Thioredoxin reductase: a target for gold compounds acting as potential anticancer drugs|
A Bindoli, MP Rigobello, G Scutari, C Gabbiani, A Casini, L Messori
Coordination Chemistry Reviews 253 (11-12), 1692-1707, 2009
|Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies|
S Nobili, E Mini, I Landini, C Gabbiani, A Casini, L Messori
Medicinal research reviews 30 (3), 550-580, 2010
|Gold (III) complexes as potential antitumor agents: solution chemistry and cytotoxic properties of some selected gold (III) compounds|
L Messori, F Abbate, G Marcon, P Orioli, M Fontani, E Mini, T Mazzei, ...
Journal of medicinal chemistry 43 (19), 3541-3548, 2000
|The binding properties of two antitumor ruthenium (III) complexes to apotransferrin.|
F Kratz, M Hartmann, B Keppler, L Messori
Journal of Biological Chemistry 269 (4), 2581-2588, 1994
|Emerging protein targets for anticancer metallodrugs: inhibition of thioredoxin reductase and cathepsin B by antitumor ruthenium (II)− arene compounds|
A Casini, C Gabbiani, F Sorrentino, MP Rigobello, A Bindoli, TJ Geldbach, ...
Journal of medicinal chemistry 51 (21), 6773-6781, 2008
|Gold (III) complexes with bipyridyl ligands: solution chemistry, cytotoxicity, and DNA binding properties|
G Marcon, S Carotti, M Coronnello, L Messori, E Mini, P Orioli, T Mazzei, ...
Journal of Medicinal Chemistry 45 (8), 1672-1677, 2002
|Clioquinol, a drug for Alzheimer's disease specifically interfering with brain metal metabolism: structural characterization of its zinc (II) and copper (II) complexes|
M Di Vaira, C Bazzicalupi, P Orioli, L Messori, B Bruni, P Zatta
Inorganic chemistry 43 (13), 3795-3797, 2004
|Gold (III) compounds as anticancer agents: Relevance of gold–protein interactions for their mechanism of action|
A Casini, C Hartinger, C Gabbiani, E Mini, PJ Dyson, BK Keppler, ...
Journal of inorganic biochemistry 102 (3), 564-575, 2008
|Metal ions in biological systems|
H Sigel, RKO Sigel
Metal Ions in Biological Systems 43, 2005
|Gold complexes inhibit mitochondrial thioredoxin reductase: consequences on mitochondrial functions|
MP Rigobello, L Messori, G Marcon, MA Cinellu, M Bragadin, A Folda, ...
Journal of inorganic biochemistry 98 (10), 1634-1641, 2004
|Structural and solution chemistry, antiproliferative effects, and DNA and protein binding properties of a series of dinuclear gold (III) compounds with bipyridyl ligands|
A Casini, MA Cinellu, G Minghetti, C Gabbiani, M Coronnello, E Mini, ...
Journal of medicinal chemistry 49 (18), 5524-5531, 2006
|Metal-based drugs for malaria, trypanosomiasis and leishmaniasis: recent achievements and perspectives|
M Navarro, C Gabbiani, L Messori, D Gambino
Drug discovery today 15 (23-24), 1070-1078, 2010
|A spectroscopic study of the reaction of NAMI, a novel ruthenium (III) anti‐neoplastic complex, with bovine serum albumin|
L Messori, P Orioli, D Vullo, E Alessio, E Iengo
European journal of biochemistry 267 (4), 1206-1213, 2000
|Gold (III) compounds as anticancer drugs|
C Gabbiani, A Casini, L Messori
Gold Bulletin 40 (1), 73-81, 2007
|Formation of supramolecular structures between DNA and starburst dendrimers studied by EPR, CD, UV, and melting profiles|
MF Ottaviani, F Furini, A Casini, NJ Turro, S Jockusch, DA Tomalia, ...
Macromolecules 33 (21), 7842-7851, 2000
|DNA as a possible target for antitumor ruthenium (III) complexes: a spectroscopic and molecular biology study of the interactions of two representative antineoplastic ruthenium …|
E Gallori, C Vettori, E Alessio, FG Vilchez, R Vilaplana, P Orioli, A Casini, ...
Archives of biochemistry and biophysics 376 (1), 156-162, 2000
|Molecular mechanisms and proposed targets for selected anticancer gold compounds|
A Casini, L Messori
Current topics in medicinal chemistry 11 (21), 2647-2660, 2011
|Chemistry, antiproliferative properties, tumor selectivity, and molecular mechanisms of novel gold (III) compounds for cancer treatment: a systematic study|
A Casini, G Kelter, C Gabbiani, MA Cinellu, G Minghetti, D Fregona, ...
JBIC Journal of Biological Inorganic Chemistry 14 (7), 1139-1149, 2009
|Aluminum, copper, iron and zinc differentially alter amyloid-Aβ1–42 aggregation and toxicity|
S Bolognin, L Messori, D Drago, C Gabbiani, L Cendron, P Zatta
The international journal of biochemistry & cell biology 43 (6), 877-885, 2011
|Mechanisms of cytotoxicity of selected organogold (III) compounds|
M Coronnello, E Mini, B Caciagli, MA Cinellu, A Bindoli, C Gabbiani, ...
Journal of medicinal chemistry 48 (21), 6761-6765, 2005